Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
| Image |  |
|---|---|
| Description | scientific article published on 24 August 2016 |
| Author/s |
author: Edward Favours Raushan T Kurmasheva Malcolm A Smith Peter J. Houghton |
| Publication date | August 24, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |